There are certain Quality MIPS Measures you may want to avoid in 2018, as CMS has determined them to be “topped out” vs. other options. There are nuances to the discussion, but essentially these measures don’t afford maximum points and won’t optimize your score. As such, may make sense to choose other measures expected to have a longer shelf-life with a better opportunity for elevated scoring.
Here are some examples:
- Measure 21: Perioperative Care: Selection of Prophylactic Antibiotic-First or Second-Generation Cephalosporin
- Measure 23: Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)
- Measure 52: Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy
- Measure 224: Melanoma: Overutilization of Imaging Studies in Melanoma
- Measure 262: Image Confirmation of Successful Excision of Image-Localized Breast Lesion
- Measure 359: Optimizing Patient Exposure to Ionizing Radiation: Utilization of a Standardized Nomenclature for Computerized Tomography (CT) Imaging Description
If you want to learn more about the granular aspects of how and why a measure becomes “topped out” and what that means for you, details can be found here on page 9.